Achievwin
★    

US,
2021-07-06 16:37
(996 d 01:30 ago)

Posting: # 22459
Views: 1,641
 

 BE for a drug dosed on body weight [Study Per­for­mance]

Has anyone have experience in designing bioequivalence trial for a (oncology or other) drug which dosing varies with body weight (varying doses)? How do you present PK across subjects receiving varying doses (dose normalize to a bench mark dose? or since BE is based on ratio it has no impact?)

Thanks for any feed back:-|
dshah
★★  

India/United Kingdom,
2021-07-17 13:46
(985 d 04:21 ago)

@ Achievwin
Posting: # 22475
Views: 1,237
 

 BE for a drug dosed on body weight

Dear Achievwin!
If the study is crossover, then the dose administered would generally be same for that subject and thus we could assume that it would not have any impact.
Regards,
Dshah
UA Flag
Activity
 Admin contact
22,957 posts in 4,819 threads, 1,638 registered users;
73 visitors (0 registered, 73 guests [including 8 identified bots]).
Forum time: 17:08 CET (Europe/Vienna)

Nothing shows a lack of mathematical education more
than an overly precise calculation.    Carl Friedrich Gauß

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5